Avatar
Angerhawk62

0 Following 0 Followers
1
Eption whether the vector administration occurred at 2 weeks or 6 weeks following injury (p > 0.05 for all behavioral tests). The only difference was detected at 5 weeks post injection for mechanical hyperalgesia, when animals injected at 2 weeks post SCI showed significantly higher sensitivity to mechanical pressure than animals injected at 6 weeks (p
1
Observations thus far, it appears that neuronal cells are transfected at higher levels than glial cells.Immunodot-blot analysisThe immunodot-blot analysis (Figure 12) indicated the presence of EMs (A) and SHG (B) in cerebrospinal fluid of the animals injected with the viral vectors and the presence of SHG in the spinal cord tissue of treated animals (C). The intensity of the immunoreactive spots s
1
D the antinociceptive effects of viral vectors, asBased on the behavioral results, we examined the expression of the endomorphins and serine histogranin in the dorsal horn of the spinal cord seven weeks after viral vector injection. Sections were labeled for endomorphins or SHG immunoreactivity. Immunoreactive positive cells for SHG (A) and endomorphins (B) were seen in the dorsal horn at the 7th
1
Rop in withdrawal threshold (Von Frey test) and increased sensitivity to cold stimuli (acetone test) compared to pre-injection responses (P
1
Observations thus far, it appears that neuronal cells are transfected at higher levels than glial cells.Immunodot-blot analysisThe immunodot-blot analysis (Figure 12) indicated the presence of EMs (A) and SHG (B) in cerebrospinal fluid of the animals injected with the viral vectors and the presence of SHG in the spinal cord tissue of treated animals (C). The intensity of the immunoreactive spots s
1
Observations thus far, it appears that neuronal cells are transfected at higher levels than glial cells.Immunodot-blot analysisThe immunodot-blot analysis (Figure 12) indicated the presence of EMs (A) and SHG (B) in cerebrospinal fluid of the animals injected with the viral vectors and the presence of SHG in the spinal cord tissue of treated animals (C). The intensity of the immunoreactive spots s